—Late-breaking BIOADAPTOR RCT data to highlight two-year clinical outcomes of the DynamX Bioadaptor, the first therapy designed to restore coronary artery hemodynamic modulation and improve PCI ...
MedPage Today on MSN
Downward Dog for Opioid Withdrawal?
"Opioid withdrawal is notoriously difficult to treat," and these findings suggest that yoga helped patients stabilize from ...
A large U.S. randomized trial published in the New England Journal of Medicine found that etomidate, compared with ketamine, ...
News-Medical.Net on MSN
AI language models actually help in digestive disease care
Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...
VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation (PNS) System utilizing their ...
The BigpAK-2 randomized prospective multicenter trial tested implementation of a bundle of measures to prevent acute kidney injury in high-risk patients undergoing major surgery. Trial results support ...
Impact of Lean Body Mass–Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial The trials were conducted ...
News-Medical.Net on MSN
Low-dose megestrol strengthens hormone therapy in ER-positive breast cancer
Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...
A large trial of people with earlier stages of prostate cancer compared two types of external radiation treatments head-to-head—proton beam therapy and intensity-modulated radiation therapy, or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results